Tau conformational changes correspond to impairments of episodic memory in mild cognitive impairment and Alzheimer's disease

被引:164
作者
Ghoshal, N
García-Sierra, F
Wuu, J
Leurgans, S
Bennett, DA
Berry, RW
Binder, LI
机构
[1] Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA
[2] Northwestern Univ, Feinberg Sch Med, Cognit Neurol & Alzheimers Dis Ctr, Chicago, IL 60611 USA
[3] Rush Presbyterian St Lukes Med Ctr, Rush Alzheimers Dis Ctr, Chicago, IL 60612 USA
[4] Rush Presbyterian St Lukes Med Ctr, Dept Neurol Sci, Chicago, IL 60612 USA
关键词
Alzheimer's disease; Tau; conformation; episodic memory; antibody; epitope;
D O I
10.1006/exnr.2002.8014
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
A multitiered strategy was adopted to assess tau conformational changes within fibrillar lesions during the progression of Alzheimer's disease (AD). Anti-tau monoclonal antibodies whose epitopes are distributed across much of the molecule were used to probe vulnerable brain regions in 37 clinically staged cases obtained from the Religious Orders Study. In this way, tau conformational changes were evaluated as the disease progressed from early cognitive decline to AD. These analyses revealed three main findings. First, the presence of granulovacuolar and fibrillar lesions correlates with several measures of episodic memory, suggesting that these lesions significantly contribute to cognitive dysfunction. Second, neuropil threads precede the appearance of neurofibrillary tangles that in turn precede the appearance of neuritic plaques. Third, tau structural changes, or "conformational signatures," emerged as a result of in situ reactivity to a subset of antibodies and nonreactivity to others, thereby reflecting the underlying status of the tau molecule within the fibrillar lesions. These signatures allowed us to document a sequence of tau conformational changes that occur during AD and to correlate these changes with episodic memory deficits. Furthermore, we were able to compare conformational signatures of tau among different lesion types and determine that the molecular profile of tau is lesion-specific. (C) 2002 Elsevier Science (USA).
引用
收藏
页码:475 / 493
页数:19
相关论文
共 85 条
[11]   IMMUNOHISTOCHEMICAL STAGING OF NEUROFIBRILLARY DEGENERATION IN ALZHEIMERS-DISEASE [J].
BONDAREFF, W ;
HARRINGTON, C ;
WISCHIK, CM ;
HAUSER, DL ;
ROTH, M .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1994, 53 (02) :158-164
[12]   A SEQUENCE OF CYTOSKELETON CHANGES RELATED TO THE FORMATION OF NEUROFIBRILLARY TANGLES AND NEUROPIL THREADS [J].
BRAAK, E ;
BRAAK, H ;
MANDELKOW, EM .
ACTA NEUROPATHOLOGICA, 1994, 87 (06) :554-567
[13]   Frequency of stages of Alzheimer-related lesions in different age categories [J].
Braak, H ;
Braak, E .
NEUROBIOLOGY OF AGING, 1997, 18 (04) :351-357
[14]   NEUROPATHOLOGICAL STAGING OF ALZHEIMER-RELATED CHANGES [J].
BRAAK, H ;
BRAAK, E .
ACTA NEUROPATHOLOGICA, 1991, 82 (04) :239-259
[15]   QUANTIFYING THE PATTERN OF BETA/A4 AMYLOID PROTEIN DISTRIBUTION IN ALZHEIMERS-DISEASE BY IMAGE-ANALYSIS [J].
BRUCE, CV ;
CLINTON, J ;
GENTLEMAN, SM ;
ROBERTS, GW ;
ROYSTON, MC .
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 1992, 18 (02) :125-136
[16]   AD2, a phosphorylation-dependent monoclonal antibody directed against tau proteins found in Alzheimer's disease [J].
BueeScherrer, V ;
Condamines, O ;
MourtonGilles, C ;
Jakes, R ;
Goedert, M ;
Pau, B ;
Delacourte, A .
MOLECULAR BRAIN RESEARCH, 1996, 39 (1-2) :79-88
[17]   BETA-AMYLOID PROTEIN LOAD IS RELATIVELY UNIFORM THROUGHOUT NEOCORTEX AND HIPPOCAMPUS IN ELDERLY ALZHEIMERS-DISEASE PATIENTS [J].
CAIRNS, NJ ;
CHADWICK, A ;
LUTHERT, PJ ;
LANTOS, PL .
NEUROSCIENCE LETTERS, 1991, 129 (01) :115-118
[18]   The structural basis of monoclonal antibody Alz50's selectivity for Alzheimer's disease pathology [J].
Carmel, G ;
Mager, EM ;
Binder, LI ;
Kuret, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (51) :32789-32795
[19]   Down-regulation of trkA mRNA within nucleus basalis neurons in individuals with mild cognitive impairment and Alzheimer's disease [J].
Chu, YP ;
Cochran, EJ ;
Bennett, DA ;
Mufson, EJ ;
Kordower, JH .
JOURNAL OF COMPARATIVE NEUROLOGY, 2001, 437 (03) :296-307
[20]   NEW IMMUNOASSAY FOR THE MAPPING OF NEUROFIBRILLARY DEGENERATION IN ALZHEIMERS-DISEASE USING 2 MONOCLONAL-ANTIBODIES AGAINST HUMAN PAIRED HELICAL FILAMENT TAU PROTEINS [J].
CONDAMINES, O ;
BUEESCHERRER, V ;
BOISSIER, L ;
WATTEZ, A ;
DELACOURTE, A ;
PAU, B ;
MOURTONGILLES, C .
NEUROSCIENCE LETTERS, 1995, 192 (02) :81-84